These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

448 related items for PubMed ID: 18636260

  • 21. Regimen-related mucosal injury of the gut increased the incidence of CMV disease after allogeneic bone marrow transplantation.
    Shigematsu A, Yasumoto A, Yamamoto S, Sugita J, Kondo T, Onozawa M, Kahata K, Endo T, Ota S, Sato N, Takahata M, Okada K, Tanaka J, Hashino S, Nishio M, Koike T, Asaka M, Imamura M.
    Biol Blood Marrow Transplant; 2009 Jun; 15(6):679-85. PubMed ID: 19450752
    [Abstract] [Full Text] [Related]

  • 22. Successful engraftment of mismatched unrelated cord blood transplantation following reduced intensity preparative regimen using fludarabine and busulfan.
    Komatsu T, Narimatsu H, Yoshimi A, Kurita N, Kusakabe M, Hori A, Murashige N, Matsumura T, Kobayashi K, Yuji K, Tanaka Y, Kami M.
    Ann Hematol; 2007 Jan; 86(1):49-54. PubMed ID: 17036221
    [Abstract] [Full Text] [Related]

  • 23. Engraftment and survival following hematopoietic stem cell transplantation for osteopetrosis using a reduced intensity conditioning regimen.
    Tolar J, Bonfim C, Grewal S, Orchard P.
    Bone Marrow Transplant; 2006 Dec; 38(12):783-7. PubMed ID: 17086207
    [Abstract] [Full Text] [Related]

  • 24. Multilineage hematopoietic engraftment after allogeneic peripheral blood stem cell transplantation without conditioning in SCID patients.
    Bielorai B, Trakhtenbrot L, Amariglio N, Rothman R, Tabori U, Dallal I, Golan H, Neumann Y, Reichart M, Kaplinsky C, Rechavi G, Toren A.
    Bone Marrow Transplant; 2004 Aug; 34(4):317-20. PubMed ID: 15220954
    [Abstract] [Full Text] [Related]

  • 25. Liver chimerism after allogeneic blood stem cell transplantation.
    ten Hove WR, Verspaget HW, Barge R, Lamers CB, van Hoek B.
    Transplant Proc; 2007 Aug; 39(1):231-6. PubMed ID: 17275511
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. A murine model of antimetabolite-based, submyeloablative conditioning for bone marrow transplantation: biologic insights and potential applications.
    Goebel WS, Pech NK, Meyers JL, Srour EF, Yoder MC, Dinauer MC.
    Exp Hematol; 2004 Dec; 32(12):1255-64. PubMed ID: 15588950
    [Abstract] [Full Text] [Related]

  • 28. Induction of mixed chimerism through transplantation of CD45-congenic mobilized peripheral blood stem cells after nonmyeloablative irradiation.
    Koporc Z, Bigenzahn S, Blaha P, Fariborz E, Selzer E, Sykes M, Muehlbacher F, Wekerle T.
    Biol Blood Marrow Transplant; 2006 Mar; 12(3):284-92. PubMed ID: 16503497
    [Abstract] [Full Text] [Related]

  • 29. Sequential intensified conditioning and tapering of prophylactic immunosuppressants for graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for refractory leukemia.
    Liu QF, Fan ZP, Zhang Y, Jiang ZJ, Wang CY, Xu D, Sun J, Xiao Y, Tan H.
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1376-85. PubMed ID: 19822296
    [Abstract] [Full Text] [Related]

  • 30. Influence of killer immunoglobulin-like receptor/HLA ligand matching on achievement of T-cell complete donor chimerism in related donor nonmyeloablative allogeneic hematopoietic stem cell transplantation.
    Sobecks RM, Ball EJ, Askar M, Theil KS, Rybicki LA, Thomas D, Brown S, Kalaycio M, Andresen S, Pohlman B, Dean R, Sweetenham J, Macklis R, Bernhard L, Cherni K, Copelan E, Maciejewski JP, Bolwell BJ.
    Bone Marrow Transplant; 2008 Apr; 41(8):709-14. PubMed ID: 18195688
    [Abstract] [Full Text] [Related]

  • 31. Impact of T cell chimerism on clinical outcome in 117 patients who underwent allogeneic stem cell transplantation with a busulfan-containing reduced-intensity conditioning regimen.
    Saito B, Fukuda T, Yokoyama H, Kurosawa S, Takahashi T, Fuji S, Takahashi N, Tajima K, Kim SW, Mori SI, Tanosaki R, Takaue Y, Heike Y.
    Biol Blood Marrow Transplant; 2008 Oct; 14(10):1148-1155. PubMed ID: 18804045
    [Abstract] [Full Text] [Related]

  • 32. [Mini-transplantation from cord blood].
    Miyakoshi S.
    Nihon Rinsho; 2003 Sep; 61(9):1555-60. PubMed ID: 14515723
    [Abstract] [Full Text] [Related]

  • 33. Comparison of outcomes after transplantation of peripheral blood stem cells versus bone marrow following an identical nonmyeloablative conditioning regimen.
    Dey BR, Shaffer J, Yee AJ, McAfee S, Caron M, Power K, Ting DT, Colby C, Preffer F, Ballen K, Attar E, Saidman S, Tarbell N, Sachs D, Sykes M, Spitzer TR.
    Bone Marrow Transplant; 2007 Jul; 40(1):19-27. PubMed ID: 17468773
    [Abstract] [Full Text] [Related]

  • 34. Allogeneic hematopoietic stem cell transplantation in myelofibrosis: the 20-year experience of the Gruppo Italiano Trapianto di Midollo Osseo (GITMO).
    Patriarca F, Bacigalupo A, Sperotto A, Isola M, Soldano F, Bruno B, van Lint MT, Iori AP, Santarone S, Porretto F, Pioltelli P, Visani G, Iacopino P, Fanin R, Bosi A, GITMO.
    Haematologica; 2008 Oct; 93(10):1514-22. PubMed ID: 18728030
    [Abstract] [Full Text] [Related]

  • 35. Recombinant human erythropoietin therapy after allogeneic hematopoietic cell transplantation with a nonmyeloablative conditioning regimen: low donor chimerism predicts for poor response.
    Vanstraelen G, Baron F, Willems E, Bonnet C, Hafraoui K, Frère P, Fillet G, Beguin Y.
    Exp Hematol; 2006 Jul; 34(7):841-50. PubMed ID: 16797411
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Costs of hematopoietic cell transplantation: comparison of umbilical cord blood and matched related donor transplantation and the impact of posttransplant complications.
    Majhail NS, Mothukuri JM, Brunstein CG, Weisdorf DJ.
    Biol Blood Marrow Transplant; 2009 May; 15(5):564-73. PubMed ID: 19361748
    [Abstract] [Full Text] [Related]

  • 38. A myeloablative conditioning regimen for patients with impaired cardiac function undergoing allogeneic stem cell transplantation: reduced cyclophosphamide combined with etoposide and total body irradiation.
    Yoshimi A, Nannya Y, Sakata-Yanagimoto M, Oshima K, Takahashi T, Kanda Y, Motokura T, Chiba S, Kurokawa M.
    Am J Hematol; 2008 Aug; 83(8):635-9. PubMed ID: 18506704
    [Abstract] [Full Text] [Related]

  • 39. Quantitative analysis of chimerism after allogeneic stem cell transplantation by real-time polymerase chain reaction with single nucleotide polymorphisms, standard tandem repeats, and Y-chromosome-specific sequences.
    Koldehoff M, Steckel NK, Hlinka M, Beelen DW, Elmaagacli AH.
    Am J Hematol; 2006 Oct; 81(10):735-46. PubMed ID: 16838323
    [Abstract] [Full Text] [Related]

  • 40. Early identification and management of graft failure after unrelated cord blood transplantation.
    Chan KW, Grimley MS, Taylor C, Wall DA.
    Bone Marrow Transplant; 2008 Jul; 42(1):35-41. PubMed ID: 18332909
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.